Coming Soon

« Company Overview
43,139
2021-01-01 to 2021-03-31
Collaborative R&D
Black, Asian and Minority Ethnic (BAME) people are more likely than Caucasians to have high blood pressure (HBP) or Type2 diabetes (T2D). The UK has ~4 million people with T2D (Diabetes UK, 2020). T2D is up to 6 times more likely in South Asians and 3 times more likely in Africans/Africa-Caribbeans (Ibid). Half of T2D sufferers have HBP, which is 3-4 times more likely to occur in black people of African/Africa-Caribbean descent than white people (Action on Salt, 2020). Health issues resulting from HBP/T2D cost the NHS £2.1bn annually (Public Health England, 2017). Every decade, poor monitoring of HBP/T2D causes the loss of ~7,000 quality adjusted UK life years (PHE, 2017). These losses are unsustainable and need a solution. Improvements in HBP/T2D prevention and treatment are desperately needed (South Asian Health Foundation, 2020) to avoid BAME deaths and reduce the cost of these diseases to the NHS. A remote monitoring solution for HBP/T2D in the BAME population could address healthcare inequalities exposed by Covid-19; reduce cases requiring intervention (Kim, 2020); and save the NHS millions previously spent on the fallout of poor disease monitoring. Critically, it could save BAME lives. We offer an alternative solution to the current, high-cost and ineffective approach to HBP/T2D monitoring that is failing the BAME population during the Covid-19 pandemic. Through CheckUp, BAME HBP/T2D patients self-monitor and remotely report to healthcare professionals. CheckUp reduces required GP appointments for BAME HBP/T2D patients, saving the NHS money and reducing the exposure of BAME HBP/T2D to Covid-19 by providing remote monitoring.